Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 14, 2014

Primary Completion Date

April 15, 2026

Study Completion Date

June 30, 2026

Conditions
Stage, Colon CancerStage I-III Colon CancerStage IV Colon Cancer With Resectable Liver Metastases
Interventions
DRUG

Vitamin D3

Take five 10,000 IU capsules (total 50,000 IU) once daily for 7 days, followed by one 10,000 IU capsule once daily until surgery.

DRUG

Placebo

Take five placebo capsules once daily for 7 days, followed by one placebo capsule once daily until surgery.

Trial Locations (1)

02115

RECRUITING

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pharmavite LLC

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER